drugset / Trial / NCT00343109
Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer
NaSingle-groupOpen-labelPrevention
Summary
This phase II trial is studying how well vaccine therapy works in treating patients receiving trastuzumab for HER2-positive stage IIIB- IV breast cancer. Vaccines made from peptides may help the body build an effective immune response to kill tumor cells
Timeline
- Start
- 2004-03
- Primary completion
- 2015-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HER-2/neu intracellular domain protein | Vaccine | — | Intravenous |
| Background | sargramostim | Protein / enzyme biologic | — | Intravenous |